Literature DB >> 26181671

Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy.

Yongli Ji1, Joanna Schwartz2, Alan Hartford3, Jon Ramsey1, Julie Phillips4, Claire Verschraegen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26181671     DOI： 10.1001/jamaoncol.2015.1300

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer.

Authors:  Lei Yang; Yun-Ting He; Jin Kang; Ming-Ying Zheng; Zhi-Hong Chen; Hong-Hong Yan; Xu-Chao Zhang; Jin-Ji Yang; Yi-Long Wu; Qing Zhou
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

2.  Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping.

Authors:  Ibiayi Dagogo-Jack; Justin F Gainor; Rebecca L Porter; Katherine R Schultz; Benjamin J Solomon; Sara Stevens; Christopher G Azzoli; Lecia V Sequist; Inga T Lennes; Alice T Shaw
Journal:  J Thorac Oncol       Date:  2016-06-11       Impact factor: 15.609

3.  Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy.

Authors:  Gina Amanda; Agus Dwi Susanto; Dicky Soehardiman; Dianiati Kusumo Sutoyo; Yuyun Lisnawati; Boy Busmar; Andika Chandra Putra; Erlang Samoedro; Elisna Syahruddin
Journal:  Lung India       Date:  2017 Nov-Dec

4.  Rapid Progression of Lung Cancer Following Emergency Caesarean Section Led to Postpartum Acute Respiratory Failure.

Authors:  Tamami Watanabe; Takeshi Yamashita; Hitoshi Sugawara; Takahiko Fukuchi; Akira Ishii; Yoshiaki Nagai; Fumiyoshi Ohyanagi; Shinichiro Koyama; Junko Ushijima; Kenjiro Takagi; Akira Tanaka
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.